| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 11/07/1996 | CA2220156A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 11/06/1996 | EP0740555A1 Preparation of bone for transplantation |
| 11/06/1996 | EP0740551A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors |
| 11/06/1996 | CN1134817A Iodine pharmaceutics and method for prepn. of same |
| 11/05/1996 | US5571801 Plasma expander and blood substitute |
| 11/05/1996 | US5571794 Applying vasodilator to lips to increase size |
| 11/05/1996 | US5571535 Treatment of topical infections |
| 11/05/1996 | US5571532 Pharmaceutical preparation for supplying fluoride ions |
| 11/05/1996 | US5571520 Molecular crystal redox device for pharmaceuticals |
| 11/05/1996 | US5571501 Denyifrice |
| 11/05/1996 | US5571186 Porous hydroxyapatite or tricalcium phosphate, 7-isopropoxyisoflavone |
| 11/05/1996 | US5570683 Methods and devices for treating pulmonary vasoconstriction and asthma |
| 10/30/1996 | EP0739629A1 Associations comprising (-)hydroxycitrate and having new therapeutical activities |
| 10/30/1996 | EP0739210A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
| 10/30/1996 | EP0739209A1 Method for treatment of papulo-pustules and comedones of the skin |
| 10/30/1996 | CN1134249A Preparation of health salt |
| 10/29/1996 | US5569678 Administering a calcium antagonist to scar site for a time period sufficient to cause extracellular matrix degradation |
| 10/29/1996 | US5569648 Administering insulin-like growth factor |
| 10/29/1996 | US5569590 Initial screen for abnormal platelet condition |
| 10/24/1996 | WO1996032952A1 Caffeine composition as medicament and use thereof |
| 10/23/1996 | EP0738142A1 Perfluorocarbons as anti-inflammatory agents |
| 10/23/1996 | EP0738114A1 Food products for preventing development of diseases and process for preparing same |
| 10/23/1996 | EP0477339B1 Hydroxyapatite-antigen conjugates and methods for generating a poly-ig immune response |
| 10/23/1996 | EP0416094B1 Parathyroid hypertensive factor |
| 10/23/1996 | CN1133726A "Qingsongsan" medicinal liquor or ointment and preparing and use method thereof |
| 10/22/1996 | US5567724 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders |
| 10/17/1996 | WO1996032120A1 Anionic oxygen radicals containing therapeutic agents and their use in pain relief |
| 10/17/1996 | WO1996032115A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers |
| 10/17/1996 | WO1996032107A1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
| 10/17/1996 | CA2217951A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers |
| 10/16/1996 | EP0737478A1 Use of alkaline earth metal salts for the treatment of pruritis, eye or eyelid pain or disesthesies |
| 10/16/1996 | EP0737474A2 Benzoyl peroxide compositions |
| 10/16/1996 | EP0737471A2 Use of alkaline earth metal salts as TNF-alpha inhibitor in a topical composition and composition obtained therefrom |
| 10/16/1996 | EP0737067A1 Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 10/16/1996 | CN1133293A Platinum matches and medicine for malignant tumor containing said platinum matches |
| 10/16/1996 | CN1133189A Oral liquid for body building up |
| 10/16/1996 | CN1133181A Qiangweisan (medicinal powder for invigorating the function of stomach) preparation process |
| 10/15/1996 | US5565190 Dentifrice compositions containing reactive ingredients stabilized with alkali metal compounds |
| 10/10/1996 | WO1996031222A1 Antiasthmatic preparation |
| 10/10/1996 | WO1996031221A1 Preparation of sodium chloride aerosol formulations |
| 10/10/1996 | WO1996031219A1 Inhibition of c. difficile infections by indigestible oligosaccharides |
| 10/10/1996 | WO1996031215A1 Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism |
| 10/10/1996 | WO1996031130A2 Calcium supplements and calcium containing beverages comprising vitamin d |
| 10/10/1996 | CA2217264A1 Calcium supplements and calcium containing beverages comprising vitamin d |
| 10/09/1996 | EP0517740B1 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
| 10/09/1996 | EP0457921B1 Novel platinum (ii) complex and drug for treating malignant tumor |
| 10/09/1996 | CN1132626A Improved calcium dietary supplement |
| 10/08/1996 | US5563132 Two-step cancer treatment method |
| 10/08/1996 | US5563124 Osteogenic product and process |
| 10/08/1996 | US5562925 Anti-tumor method |
| 10/08/1996 | US5562901 Administering activated charcoal spheres |
| 10/08/1996 | US5562895 Methods and compositions for mineralizing and flouridating calcified tissues |
| 10/03/1996 | WO1996030029A1 Pharmaceutical composition containing selected lanthanum carbonate hydrates |
| 10/02/1996 | EP0734726A2 Composition containing mercury ammonium chloride, resorcinol and sulphur |
| 10/02/1996 | EP0734721A2 Method of incorporating drugs into a polymer component of stents |
| 10/02/1996 | EP0734285A1 Deep-bed filter for exterminating micro-organisms and inactivating viruses and its use |
| 10/02/1996 | EP0275285B1 Biodegradable superparamagnetic materials used in clinical applications |
| 10/02/1996 | CN1132084A Chinese medicine for curing haemorrhoids inflammation and its prepn. process |
| 10/02/1996 | CN1132078A Burn medicine and prepn. method thereof |
| 10/02/1996 | CN1132075A Agent for reducing nephrotoxicity due to medicine |
| 10/02/1996 | CN1132074A High effective Ca-blood nourishing oral liquid and its prepn. method |
| 10/02/1996 | CN1032899C Face film for sore |
| 10/01/1996 | US5561160 Administering glucaric acid or salt thereof |
| 10/01/1996 | US5561136 Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent |
| 10/01/1996 | US5560935 Administering to inhibit plasma kallikrein production: improves peripheral blood flow, exhibits analgesic, antiinflammatory and antiallergic properties |
| 10/01/1996 | US5560816 Method for electrolyzing fluids |
| 10/01/1996 | CA2045266C Peroxide gel dentifrice |
| 09/26/1996 | WO1996024364A3 Antimicrobial composition composed of controlled release glasses |
| 09/26/1996 | WO1996023504A3 Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates |
| 09/26/1996 | DE19510229A1 Bismuth complexes with tropolone, thiosemicarbazone or di:thiocarbazonic acid ester cpds. |
| 09/25/1996 | EP0733590A1 Salt having more than 99,0% by weight sodium chloride and its use |
| 09/25/1996 | EP0732932A1 Use of urinastatin-like compounds to prevent premature delivery |
| 09/25/1996 | EP0732918A1 Benzalkonium fluoride injectable solution |
| 09/25/1996 | EP0732917A1 Nutritional supplement for optimizing cellular health |
| 09/25/1996 | CN1131696A Enriched vinegar product and method of making the same |
| 09/25/1996 | CN1131541A Western medicine compound for fever abatement |
| 09/25/1996 | CN1131540A Preparation method of medicine for curing syphilopathy |
| 09/25/1996 | CA2171174A1 Salt containing more than 99,0 % per weight of sodium chloride and use thereof |
| 09/24/1996 | US5558870 Method for maintaining a continuously-saturated level of ascorbic acid in a patient's body |
| 09/24/1996 | US5558858 Co-dried aluminum oxyhydroxides |
| 09/19/1996 | WO1996028173A1 Biocidal compositions containing halides and oxyhalides |
| 09/19/1996 | WO1996028172A1 Pharmaceutical compositions for controlling unitary smooth muscle polarisation |
| 09/19/1996 | WO1996028171A1 Method for treating acne and/or rosacea |
| 09/19/1996 | WO1996028168A1 Methods for the treatment of thrombosis |
| 09/19/1996 | WO1996028142A1 Method and kit for preventing erectile dysfunction |
| 09/19/1996 | WO1996028136A1 Sunscreen compositions comprising a mixture of titanium and/or zinc oxide particles, method for preparing the same and use thereof |
| 09/19/1996 | CA2215336A1 Methods for the treatment of thrombosis |
| 09/19/1996 | CA2215307A1 Pharmaceutical compositions and kits for preventing erectile dysfunction |
| 09/19/1996 | CA2215232A1 Method for treating acne and/or rosacea |
| 09/18/1996 | EP0731711A1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents |
| 09/18/1996 | EP0731707A1 Use of lithium salts for reducing structural defects in a human lens |
| 09/18/1996 | EP0461105B1 Composition for prevention of plaque formation and plaque dependent diseases |
| 09/18/1996 | CN1131393A Biochemically balanced peritoneal dialysis solutions |
| 09/18/1996 | CN1131392A Nitric oxide donor composition and method for treatment of anal disorders |
| 09/18/1996 | CN1131037A Yingfengaidi medicine and its production process |
| 09/18/1996 | CN1131032A Chuangshangling traditional Chinese medicine preparation for curing burn and scald and its preparing method |
| 09/18/1996 | CN1131022A Qufushengjisan powder medicine capable of removing putrid tissues and promoting growth of new tissues and shengjisan powder |
| 09/18/1996 | CN1131020A Medicine for reducing blood sugar and its preparation method and use |
| 09/18/1996 | CN1131001A Method for preparation of mineral water containing natural iodine |
| 09/18/1996 | CA2144885A1 Enriched vinegar product and method of making the same |